Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Acadia Pharmaceuticals buy Canaccord Genuity Group Inc.

Acadia Pharmaceuticals
Start price
€22.05
29.06.26 / 50%
Target price
€31.62
29.06.27
Performance (%)
18.19%
Price
€26.06
18.08.26
Summary
This prediction is currently active. The BUY prediction by Canaccord_Genuity_Gr currently has a performance of 18.19%. This prediction currently runs until 29.06.27. The prediction end date can be changed by Canaccord_Genuity_Gr at any time. Canaccord_Genuity_Gr has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Acadia Pharmaceuticals 2.316% 2.316%
iShares Core DAX® -0,87 % 5,32 %
iShares Nasdaq 100 -0,38 % 1,98 %
iShares Nikkei 225® -1,68 % 1,95 %
iShares S&P 500 -0,65 % 2,07 %

Comments by Canaccord_Genuity_Gr for this prediction

In the thread Acadia Pharmaceuticals diskutieren
Prediction Buy
Perf. (%) 18.19%
Target price 31.622
Change
Ends at 29.06.27

ACADIA Pharmaceuticals (ACAD) had its price target raised by Canaccord Genuity Group Inc. from $32.00 to $36.00. They now have a "buy" rating on the stock.
Ratings data for ACAD provided by MarketBeat

Canaccord Genuity Group Inc. 
0
Report Share
29.06.26